Галерея 3221171
Галерея 3221171
Dashboard
Publications
Account settings
Log out
Journal List
Indian J Psychiatry
v.53(3); Jul-Sep 2011
PMC3221171
Create a new collection
Add to an existing collection
Unable to load your collection due to an error
Please try again
Indian J Psychiatry. 2011 Jul-Sep; 53(3): 187–191.
Find articles by Amresh Shrivastava
Department of Psychiatry, Elgin Early Intervention Program for Psychosis, The University of Western Ontario, Ontario, Canada, and Mental Health Resource Foundation, Mumbai, Maharashtra, India
1 Department of Psychology, University of Toronto, 100 St. George Street, Toronto, Ontario, Canada
2 Department of Psychiatry, Center for Behavioral Genomics, University of California, San Diego, CA, and Harvard Institute of Psychiatric Epidemiology and Genetics, Harvard Medical School and Harvard School of Public Health; Boston, MA, USA, and UCSD Institute for Genomic Medicine
Address for correspondence: Dr. Amresh Shrivastava, Regional Mental Health Care, 467 Sunset Drive, St. Thomas, Ontario, Canada. E-mail: moc.liamg@ude.hsermA
Copyright : © Indian Journal of Psychiatry
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. World Health Organization (WHO) Cannabis: A health perspective and research agenda. 1997. [last cited on 2011 Jun 17]. Available from:
http://whqlibdoc.who.int/hq/1997/WHO_MSA_PSA_97.4.pdf .
2. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: Cohort study. Br Med J. 2002; 325 :1195–8. [ PMC free article ] [ PubMed ] [ Google Scholar ]
3. Sethi BB, Trivedi JK, Singh H. Long term effects of cannabis. Indian J Psychiatry. 1981; 23 :224–9. [ PMC free article ] [ PubMed ] [ Google Scholar ]
4. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous Delts9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009; 31 :1607–16. [ PubMed ] [ Google Scholar ]
5. Parkarl SR, Ramanathan S, Nair N, Batral SA, Adarkarl SA, Pandit AG, et al. Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population. Indian J Psychiatry. 2010; 52 :236–42. [ PMC free article ] [ PubMed ] [ Google Scholar ]
6. Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999; 94 :1311–22. [ PubMed ] [ Google Scholar ]
7. Danseco ER, Kingery PM, Coggeshall MB. Perceived risk of harm from marijuana use among youth in the USA. School Psych Int. 1999; 20 :39–56. [ Google Scholar ]
8. Solowij N. Cannabis and cognitive functioning. Cambridge: Cambridge University Press; 1988. [ Google Scholar ]
9. Fletcher JM, Page JB, Francis DJ, Copeland K, Naus MJ, Davis CM, et al. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry. 1996; 53 :1051–7. [ PubMed ] [ Google Scholar ]
10. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use. JAMA. 1996; 275 :521–7. [ PubMed ] [ Google Scholar ]
11. Bartholomew J, Holroyd S, Heffernan TM. Does cannabis use affect prospective memory in young adults? J Psychopharmacol. 2010; 24 :241–6. [ PubMed ] [ Google Scholar ]
12. Huestegge L, Kunert HJ, Radach R. Long-term effects of cannabis on eye movement control in reading. Psychopharmacology (Berl) 2010; 209 :77–84. [ PubMed ] [ Google Scholar ]
13. Venkoba Rao A, Rawlin Chinnian R, Pradeep D, Rajagopal P. Cannabis (ganja) and cognition. Indian J Psychiatry. 1975; 17 :233–7. [ Google Scholar ]
14. Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, et al. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010; 55 :165–71. [ PubMed ] [ Google Scholar ]
15. Welch KA, McIntosh AM, Job DE, Whalley HC, Moorhead TW, Hall J, et al. The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull. 2010; 37 :1066–76. [ PMC free article ] [ PubMed ] [ Google Scholar ]
16. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, et al. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry. 2010; 44 :230–6. [ PubMed ] [ Google Scholar ]
17. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160 :636–45. [ PubMed ] [ Google Scholar ]
18. Chen WJ, Faraone SV. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet. 2000; 97 :52–7. [ PubMed ] [ Google Scholar ]
19. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002; 59 :1337–43. [ PubMed ] [ Google Scholar ]
20. Hunault CC, Mensinga TT, Bocker KB, Schipper CM, Kruidenier M, Leenders ME, et al. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC) Psychopharmacology (Berl) 2009; 204 :85–94. [ PubMed ] [ Google Scholar ]
21. Solowij N, Michie PT. Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci. 2007; 32 :30–52. [ PMC free article ] [ PubMed ] [ Google Scholar ]
22. Pope HG, Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001; 58 :909–15. [ PubMed ] [ Google Scholar ]
23. Solowij N, Stephens R, Roffman RA, Babor T. Does marijuana use cause long-term cognitive deficits? JAMA. 2002; 287 :2653–4. [ PubMed ] [ Google Scholar ]
24. Solowij N. Do cognitive impairments recover following cessation of cannabis use? Life Sc. 1995; 56 :2119–26. [ PubMed ] [ Google Scholar ]
25. Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. J Int Neuropsychol Soc. 2003; 9 :679–89. [ PubMed ] [ Google Scholar ]
26. Linszen D, van Amelsvoort T. Cannabis and psychosis: An update on course and biological plausible mechanisms. Curr Opin Psychiatry. 2007; 20 :116–20. [ PubMed ] [ Google Scholar ]
27. de la Serna E, Mayoral M, Baeza I, Arango C, Andres P, Bombin I, et al. Cognitive functioning in children and adolescents in their first episode of psychosis: Differences between previous cannabis users and nonusers. J Nerv Ment Dis. 2010; 198 :159–62. [ PubMed ] [ Google Scholar ]
28. Bossong MG, Niesink RJ. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol. 2010; 92 :370–85. [ PubMed ] [ Google Scholar ]
29. Jager G, Block RI, Luijten M, Ramsey NF. Cannabis use and memory brain function in adolescent boys: A cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry. 2010; 49 :561–72. [ PMC free article ] [ PubMed ] [ Google Scholar ]
30. Battisti RA, Roodenrys S, Johnstone SJ, Respondek C, Hermens DF, Solowij N. Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology (Berl) 2010; 209 :319–30. [ PubMed ] [ Google Scholar ]
31. Derosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK. Cannabis use disorders in schizophrenia: Effects on cognition and symptoms. Schizophr Res. 2010; 120 :95–100. [ PMC free article ] [ PubMed ] [ Google Scholar ]
32. Fadda P, Robinson L, Fratta W, Pertwee RG, Riedel G. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. Neuropharmacology. 2004; 47 :1170–9. [ PubMed ] [ Google Scholar ]
33. Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci. 2009; 12 :1152–8. [ PubMed ] [ Google Scholar ]
34. Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci. 2009; 259 :395–412. [ PubMed ] [ Google Scholar ]
35. Campolongo P, Trezza V, Palmer M, Trabace L, Cuomo V. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol. 2009; 85 :117–33. [ PubMed ] [ Google Scholar ]
36. Hall W, Degenhardt L. Cannabis use and psychosis: A review of clinical and epidemiological evidence. Aust N Z J Psychiatry. 2001; 34 :26–34. [ PubMed ] [ Google Scholar ]
37. Malone DT, Hill MN, Rubino T. Adolescent cannabis use and psychosis: Epidemiology and neurodevelopmental models. Br J Pharmacol. 2010; 160 :511–22. [ PMC free article ] [ PubMed ] [ Google Scholar ]
38. Rodrigo C, Rajapakse S. Cannabis and schizophrenia spectrum disorders: A review of clinical studies. Indian J Psycholog Med. 2009; 31 :62–70. [ PMC free article ] [ PubMed ] [ Google Scholar ]
39. Schnell T, Neisius K, Daumann J, Gouzoulis-Mayfrank E. Prevalence of psychosis/substance abuse comorbidity: Clinical-epidemiological findings from different treatment settings in a large German city. Nervenarzt. 2010; 81 :323–8. [ PubMed ] [ Google Scholar ]
40. Kulhalli V, Isaac M, Murthy P. Cannabis-related psychosis: Presentation and effect of abstinence. Indian J Psychiatry. 2007; 49 :256–61. [ PMC free article ] [ PubMed ] [ Google Scholar ]
41. Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Subjective effects of cannabis before the first psychotic episode. Aust N Z J Psychiatry. 2009; 43 :1155–62. [ PubMed ] [ Google Scholar ]
42. Loberg EM, Hugdahl K. Cannabis use and cognition in schizophrenia. Front Hum Neurosci. 2009; 3 :53. [ PMC free article ] [ PubMed ] [ Google Scholar ]
43. Kristensen K, Cadenhead KS. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res. 2007; 151 :151–4. [ PMC free article ] [ PubMed ] [ Google Scholar ]
44. Weiser M, Davidson M, Noy S. Comments on risk for schizophrenia. Schizophr Res. 2005; 79 :15–21. [ PubMed ] [ Google Scholar ]
45. Solowij N, Battisti R. The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews. 2008; 1 :81–98. [ PubMed ] [ Google Scholar ]
46. Rey JM, Sawyer MG, Raphael B, Patton GC, Lynskey M. Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry. 2002; 180 :216–21. [ PubMed ] [ Google Scholar ]
47. Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl) 2009:45–52. [ PubMed ] [ Google Scholar ]
48. Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust NZ J Psychiatry. 2007; 41 :869–84. [ PubMed ] [ Google Scholar ]
49. Coulston CM, Perdices M, Tennant CC. The neuropsychological correlates of cannabis use in schizophrenia: Lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res. 2007; 96 :169–84. [ PubMed ] [ Google Scholar ]
50. Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, et al. Implications of Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol. 2009; 33 :469–77. [ PMC free article ] [ PubMed ] [ Google Scholar ]
51. Ringen PA, Vaskinn A, Sundet K, Engh JA, Jonsdottir H, Simonsen C, et al. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med. 2009; 6 :1–11. [ PubMed ] [ Google Scholar ]
52. Degenhardt L, Tennant C, Gilmour S, Schofield D, Nash L, Hall W, et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med. 2007; 37 :927–34. [ PubMed ] [ Google Scholar ]
53. D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biol Psychiatry. 2005; 57 :594–608. [ PubMed ] [ Google Scholar ]
54. Dekker N, Smeerdijk AM, Wiers RW, Duits JH, van Gelder G, Houben K, et al. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Psychol Med. 2009; 17 :1–12. [ PubMed ] [ Google Scholar ]
55. Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, de Haan L. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Res. 2010; 181 :51–6. [ PubMed ] [ Google Scholar ]
56. Basu D, Malhotra A, Varma VK. Cannabis related psychiatric syndromes: A selective review. Indian J Psychiatry. 1994; 36 :121–8. [ PMC free article ] [ PubMed ] [ Google Scholar ]
57. Shrivastava AK, Johnston ME. Cognitive neurosciences: A new paradigm in management and outcome of schizophrenia. Indian J Psychiatry. 2010; 52 :100–5. [ PMC free article ] [ PubMed ] [ Google Scholar ]
58. Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de Fonseca F. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) 2009; 206 :531–49. [ PubMed ] [ Google Scholar ]
59. Hester R, Nestor L, Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology. 2009; 34 :2450–8. [ PMC free article ] [ PubMed ] [ Google Scholar ]
60. Jager G, Ramsey NF. (Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev. 2008; 1 :114–23. [ PubMed ] [ Google Scholar ]
61. Sofuoglu M, Sugarman DE, Carroll KM. Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol. 2010; 18 :109–19. [ PMC free article ] [ PubMed ] [ Google Scholar ]
62. Raphael B, Wooding S, Stevens G, Connor J. Comorbidity: Cannabis and complexity. J Psychiatr Pract. 2005; 11 :161–76. [ PubMed ] [ Google Scholar ]
Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications
1. World Health Organization (WHO) Cannabis: A health perspective and research agenda. 1997. [last cited on 2011 Jun 17]. Available from:
http://whqlibdoc.who.int/hq/1997/WHO_MSA_PSA_97.4.pdf . [ Ref list ]
2. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: Cohort study. Br Med J. 2002; 325 :1195–8. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
3. Sethi BB, Trivedi JK, Singh H. Long term effects of cannabis. Indian J Psychiatry. 1981; 23 :224–9. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
4. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous Delts9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009; 31 :1607–16. [ PubMed ] [ Google Scholar ] [ Ref list ]
5. Parkarl SR, Ramanathan S, Nair N, Batral SA, Adarkarl SA, Pandit AG, et al. Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population. Indian J Psychiatry. 2010; 52 :236–42. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
6. Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999; 94 :1311–22. [ PubMed ] [ Google Scholar ] [ Ref list ]
7. Danseco ER, Kingery PM, Coggeshall MB. Perceived risk of harm from marijuana use among youth in the USA. School Psych Int. 1999; 20 :39–56. [ Google Scholar ] [ Ref list ]
8. Solowij N. Cannabis and cognitive functioning. Cambridge: Cambridge University Press; 1988. [ Google Scholar ] [ Ref list ]
10. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use. JAMA. 1996; 275 :521–7. [ PubMed ] [ Google Scholar ] [ Ref list ]
11. Bartholomew J, Holroyd S, Heffernan TM. Does cannabis use affect prospective memory in young adults? J Psychopharmacol. 2010; 24 :241–6. [ PubMed ] [ Google Scholar ] [ Ref list ]
12. Huestegge L, Kunert HJ, Radach R. Long-term effects of cannabis on eye movement control in reading. Psychopharmacology (Berl) 2010; 209 :77–84. [ PubMed ] [ Google Scholar ] [ Ref list ]
13. Venkoba Rao A, Rawlin Chinnian R, Pradeep D, Rajagopal P. Cannabis (ganja) and cognition. Indian J Psychiatry. 1975; 17 :233–7. [ Google Scholar ] [ Ref list ]
14. Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, et al. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010; 55 :165–71. [ PubMed ] [ Google Scholar ] [ Ref list ]
15. Welch KA, McIntosh AM, Job DE, Whalley HC, Moorhead TW, Hall J, et al. The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull. 2010; 37 :1066–76. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
16. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, et al. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry. 2010; 44 :230–6. [ PubMed ] [ Google Scholar ] [ Ref list ]
17. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160 :636–45. [ PubMed ] [ Google Scholar ] [ Ref list ]
18. Chen WJ, Faraone SV. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet. 2000; 97 :52–7. [ PubMed ] [ Google Scholar ] [ Ref list ]
19. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002; 59 :1337–43. [ PubMed ] [ Google Scholar ] [ Ref list ]
20. Hunault CC, Mensinga TT, Bocker KB, Schipper CM, Kruidenier M, Leenders ME, et al. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC) Psychopharmacology (Berl) 2009; 204 :85–94. [ PubMed ] [ Google Scholar ] [ Ref list ]
21. Solowij N, Michie PT. Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci. 2007; 32 :30–52. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ R
Галерея 2998681
Мексиканка выебана при приеме на работу
Aurora Snow переспала с соседом на улице